Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombectomy | 18 | 2026 | 240 | 2.510 |
Why?
|
| Intracranial Aneurysm | 8 | 2026 | 370 | 1.870 |
Why?
|
| Embolization, Therapeutic | 6 | 2024 | 323 | 1.840 |
Why?
|
| Stents | 18 | 2025 | 488 | 1.800 |
Why?
|
| Endovascular Procedures | 11 | 2025 | 600 | 1.720 |
Why?
|
| Cerebral Angiography | 8 | 2024 | 294 | 1.630 |
Why?
|
| Stroke | 13 | 2024 | 1184 | 1.480 |
Why?
|
| Aneurysm, Ruptured | 4 | 2026 | 76 | 1.250 |
Why?
|
| Carotid Stenosis | 3 | 2022 | 98 | 1.250 |
Why?
|
| Radial Artery | 4 | 2022 | 54 | 1.230 |
Why?
|
| Catheters | 6 | 2026 | 78 | 1.050 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2023 | 108 | 1.040 |
Why?
|
| Transverse Sinuses | 2 | 2022 | 6 | 0.930 |
Why?
|
| Carotid Artery, Internal | 7 | 2023 | 68 | 0.900 |
Why?
|
| Brain Ischemia | 8 | 2022 | 421 | 0.870 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2023 | 24 | 0.790 |
Why?
|
| Treatment Outcome | 26 | 2026 | 5627 | 0.780 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2022 | 10 | 0.780 |
Why?
|
| Femoral Artery | 2 | 2022 | 99 | 0.760 |
Why?
|
| Central Nervous System Vascular Malformations | 5 | 2022 | 75 | 0.760 |
Why?
|
| Lithotripsy | 1 | 2022 | 10 | 0.750 |
Why?
|
| Vascular Calcification | 1 | 2022 | 25 | 0.730 |
Why?
|
| Retrospective Studies | 27 | 2026 | 6619 | 0.650 |
Why?
|
| Trastuzumab | 4 | 2023 | 18 | 0.580 |
Why?
|
| Humans | 56 | 2026 | 63527 | 0.550 |
Why?
|
| Immunoconjugates | 3 | 2023 | 91 | 0.510 |
Why?
|
| Cranial Sinuses | 3 | 2022 | 12 | 0.480 |
Why?
|
| Aged | 25 | 2026 | 14451 | 0.440 |
Why?
|
| Thrombosis | 3 | 2022 | 198 | 0.430 |
Why?
|
| Middle Aged | 27 | 2026 | 17656 | 0.400 |
Why?
|
| Aged, 80 and over | 13 | 2026 | 5468 | 0.380 |
Why?
|
| Female | 33 | 2026 | 32939 | 0.380 |
Why?
|
| Camptothecin | 3 | 2023 | 28 | 0.380 |
Why?
|
| Receptor, ErbB-2 | 3 | 2022 | 56 | 0.370 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2025 | 86 | 0.340 |
Why?
|
| Male | 30 | 2026 | 29931 | 0.330 |
Why?
|
| Cavernous Sinus | 1 | 2010 | 8 | 0.330 |
Why?
|
| Veins | 1 | 2010 | 64 | 0.320 |
Why?
|
| Aneurysm, False | 2 | 2022 | 50 | 0.310 |
Why?
|
| Anterior Cerebral Artery | 2 | 2025 | 9 | 0.290 |
Why?
|
| Pseudotumor Cerebri | 2 | 2018 | 10 | 0.290 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 61 | 0.270 |
Why?
|
| Hematoma | 2 | 2024 | 80 | 0.250 |
Why?
|
| Constriction, Pathologic | 3 | 2022 | 126 | 0.250 |
Why?
|
| Angiography | 4 | 2020 | 151 | 0.240 |
Why?
|
| Incidence | 4 | 2022 | 1372 | 0.240 |
Why?
|
| Cerebral Revascularization | 2 | 2017 | 30 | 0.230 |
Why?
|
| Reperfusion | 1 | 2025 | 37 | 0.230 |
Why?
|
| Social Class | 1 | 2026 | 136 | 0.230 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 228 | 0.230 |
Why?
|
| Endarterectomy, Carotid | 2 | 2017 | 79 | 0.220 |
Why?
|
| Platelet Function Tests | 1 | 2024 | 11 | 0.220 |
Why?
|
| Moyamoya Disease | 1 | 2024 | 12 | 0.210 |
Why?
|
| Adult | 17 | 2025 | 16895 | 0.210 |
Why?
|
| Posterior Cerebral Artery | 1 | 2023 | 13 | 0.210 |
Why?
|
| Cerebral Veins | 1 | 2023 | 36 | 0.200 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2022 | 5 | 0.200 |
Why?
|
| Registries | 2 | 2025 | 872 | 0.200 |
Why?
|
| Tinnitus | 1 | 2022 | 19 | 0.200 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2023 | 48 | 0.190 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2023 | 167 | 0.190 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 83 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 98 | 0.190 |
Why?
|
| Maytansine | 1 | 2022 | 4 | 0.190 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 68 | 0.190 |
Why?
|
| Vasospasm, Intracranial | 1 | 2022 | 30 | 0.190 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1204 | 0.190 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2022 | 17 | 0.180 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 49 | 0.180 |
Why?
|
| Carotid Arteries | 1 | 2022 | 61 | 0.180 |
Why?
|
| Nerve Block | 1 | 2022 | 52 | 0.180 |
Why?
|
| Phlebography | 2 | 2018 | 44 | 0.180 |
Why?
|
| Biosimilar Pharmaceuticals | 1 | 2022 | 29 | 0.180 |
Why?
|
| Radiography, Interventional | 2 | 2022 | 79 | 0.170 |
Why?
|
| One-Lung Ventilation | 1 | 2020 | 5 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 448 | 0.160 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2023 | 216 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2025 | 3293 | 0.160 |
Why?
|
| Brain | 3 | 2023 | 1556 | 0.160 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 99 | 0.150 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 140 | 0.150 |
Why?
|
| Intracranial Hypotension | 1 | 2018 | 7 | 0.140 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 80 | 0.140 |
Why?
|
| Workload | 1 | 2018 | 127 | 0.130 |
Why?
|
| Pneumonia | 1 | 2020 | 290 | 0.130 |
Why?
|
| Operative Time | 1 | 2017 | 91 | 0.130 |
Why?
|
| Arteries | 1 | 2017 | 80 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2025 | 570 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2019 | 514 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 127 | 0.130 |
Why?
|
| Radiation Dosage | 1 | 2017 | 133 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 1641 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 214 | 0.120 |
Why?
|
| Patient Selection | 1 | 2018 | 487 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2018 | 427 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 271 | 0.110 |
Why?
|
| Contrast Media | 1 | 2016 | 422 | 0.100 |
Why?
|
| Neurosurgery | 1 | 2013 | 29 | 0.100 |
Why?
|
| Computed Tomography Angiography | 3 | 2019 | 125 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 2463 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 144 | 0.100 |
Why?
|
| Ultrasonic Therapy | 1 | 2012 | 8 | 0.100 |
Why?
|
| Physicians | 1 | 2018 | 473 | 0.090 |
Why?
|
| Angioplasty | 1 | 2012 | 51 | 0.090 |
Why?
|
| Embolism, Paradoxical | 1 | 2012 | 14 | 0.090 |
Why?
|
| Caregivers | 1 | 2015 | 277 | 0.090 |
Why?
|
| Eating | 2 | 2022 | 139 | 0.090 |
Why?
|
| Drainage | 2 | 2023 | 154 | 0.090 |
Why?
|
| Dura Mater | 1 | 2010 | 33 | 0.080 |
Why?
|
| Catheterization | 1 | 2010 | 113 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1374 | 0.080 |
Why?
|
| Intracranial Pressure | 2 | 2018 | 19 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 980 | 0.070 |
Why?
|
| Quality of Life | 1 | 2015 | 1240 | 0.070 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 83 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2702 | 0.070 |
Why?
|
| Heart Failure | 1 | 2015 | 921 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 2 | 2021 | 243 | 0.060 |
Why?
|
| United States | 3 | 2026 | 7836 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2026 | 2571 | 0.060 |
Why?
|
| Suction | 1 | 2025 | 35 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2017 | 135 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 2184 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1278 | 0.060 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2024 | 16 | 0.050 |
Why?
|
| Mechanical Thrombolysis | 1 | 2024 | 37 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2024 | 72 | 0.050 |
Why?
|
| Japan | 1 | 2023 | 60 | 0.050 |
Why?
|
| Sympathectomy | 1 | 2022 | 5 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2023 | 120 | 0.050 |
Why?
|
| Aspirin | 1 | 2024 | 172 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cannula | 1 | 2022 | 24 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 31 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2022 | 68 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 68 | 0.050 |
Why?
|
| Circle of Willis | 1 | 2021 | 7 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 286 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2023 | 477 | 0.040 |
Why?
|
| Carotid Artery, Common | 1 | 2020 | 29 | 0.040 |
Why?
|
| Everolimus | 1 | 2020 | 22 | 0.040 |
Why?
|
| Bronchi | 1 | 2020 | 81 | 0.040 |
Why?
|
| Trachea | 1 | 2020 | 85 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 38 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2020 | 101 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2020 | 121 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 44 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 203 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 37 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4541 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1552 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4714 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 232 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 202 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2018 | 31 | 0.040 |
Why?
|
| Models, Biological | 1 | 2023 | 1182 | 0.040 |
Why?
|
| Blister | 1 | 2018 | 16 | 0.040 |
Why?
|
| Headache | 1 | 2018 | 58 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2017 | 66 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 173 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 669 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 299 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 853 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 759 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 288 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 847 | 0.030 |
Why?
|
| Hospitals | 1 | 2018 | 391 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1999 | 0.030 |
Why?
|
| Hypertension | 1 | 2019 | 590 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2013 | 17 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2015 | 263 | 0.030 |
Why?
|
| India | 1 | 2013 | 159 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2013 | 205 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 3708 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 640 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 551 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 265 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6259 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 2584 | 0.010 |
Why?
|